ctDNA analysis in patients with cancer of unknown primary and its value in guiding targeted treatment when combined with predicted cancer types by 90-gene reverse-transcription polymerase chain reaction assay.

Xin Liu,Shiyu Jiang,Xiaowei Zhang,Xiaoyan Zhou,Zhiguo Luo,Xichun Hu

ctDNA analysis in patients with cancer of unknown primary and its value in guiding targeted treatment when combined with predicted cancer types by 90-gene reverse-transcription polymerase chain reaction assay.

2021

Xin Liu
Shiyu Jiang
Xiaowei Zhang
Xiaoyan Zhou
Zhiguo Luo
Xichun Hu

e18730Background: No targeted agents except for drugs against NTRK fusion, dMMR/MSI-H or TMB-H are recommended for the treatment of cancer of unknown primary (CUP), despite of the occurrence of mul...

Keywords:

cancer of unknown primary
Medicine
value
in patient
Cancer
Reverse transcription polymerase chain reaction
Cancer research
Gene

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations